1. What are the clinical outcomes associated with the Aerobika* OPEP device? (0:04)
2. Why choose the Aerobika* device over other OPEP devices? (0:50)
* Trade-marks and registered trade-marks of Trudell Medical International.
View Part 1: Relevance of Acute Exacerbations of COPD, here.
View Part 2: Non-pharmacological Treatments for AECOPD Recovery, here.
Speaker disclosures: Brian Carlin has been on advisory panels for AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, Nonin Medical Inc., Philips Respironics, and Sunovion Pharmaceuticals Inc., and a speaker for Monaghan Medical Corporation, Philips Respironics, and Sunovion Pharmaceuticals Inc.
Filmed at the CHEST Annual Meeting, Toronto, Canada, October 2017, with support from Trudell Medical International.